Research Articles

Alisch RS, Barwick BG, Chopra P, Myrick LK, Satten GA, Conneely KN, Warren ST. (2012). Age-associated DNA methylation in pediatric populations. Genome Res 22:623-632. http://genome.cshlp.org/content/22/4/623.full.pdf

 

Myrick LK, Nakamoto-Kinoshita M, Lindor NM, Kirmani S, Cheng X, Warren ST. (2014). Fragile X syndrome due to a missense mutation. Eur J Hum Genet 22:1185-1189. http://www.nature.com/ejhg/journal/v22/n10/pdf/ejhg2013311a.pdf

 

Myrick LK, Hashimoto H, Cheng X, Warren ST. (2015). Human FMRP contains an integral tandem Agenet (Tudor) and KH motif in the amino terminal domain. Hum Mol Genet 24:1733-1740. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381759/pdf/ddu586.pdf. 

 

Myrick LK, Deng PY, Hashimoto H, Oh YM, Cho Y, Poidevin MJ, Suhl JA, Visootsak J, Cavalli V, Jin P, Cheng X, Warren ST, Klyachko VA. (2015). Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures. Proc Natl Acad Sci U S A 112:949-956. http://www.pnas.org/content/112/4/949.full.pdf. 

 

Deng PY, Carlin D, Oh YM, Myrick LK, Warren ST, Cavalli V, Klyachko VA. (2018). Voltage-Independent SK Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of Fmr1 KO mice. J Neuroscience 1593-18. https://doi.org/10.1523/JNEUROSCI.1593-18.2018. 

 

Abstracts

Khoogar L, Dodson SE, Shoemaker JT, Rees HD, Mufson E, Levey AI, Lah JJ. (2006). Identification of the ApoE receptor SorLA/LR11 as a novel component of hallmark Alzheimer’s disease-related lesions in Down syndrome. 10th International Conference on Alzheimer’s Disease and Related Disorders (ICAD). Madrid, Spain. 

 

Khoogar L, Dodson SE, Mufson E, Levey AI, Lah JJ. (2006). Identification of LR11/SorLA as a novel component of hallmark Alzheimer’s disease-related lesions in Down syndrome. Society for Neuroscience (SFN) Annual Meeting. Atlanta, GA.

 

Myrick LK, Warren ST. (2010). How does Fragile X mental retardation protein (FMRP) regulate translation? Interdisciplinary Training Conference on Developmental Disorders (ITCDD). Annapolis, MD.

 

Myrick LK, Warren ST. (2011). Determining how Fragile X Mental Retardation Protein (FMRP) functions to regulate mRNA translation. Southeast Medical Scientist Symposium (SEMSS). Atlanta, GA.

 

Myrick LK, Warren ST. (2011). Determining how Fragile X Mental Retardation Protein (FMRP) functions to regulate mRNA translation. 26th Annual National MD-PhD Student Conference. Keystone, CO.

 

Myrick LK, Nakamoto-Kinoshita M, Li X, Warren ST. (2012). Pathogenesis of novel FMR1 mutations in Fragile X Syndrome. Southeast Medical Scientist Symposium (SEMSS). Nashville, TN.

 

Myrick LK, Nakamoto-Kinoshita M, Li X, Warren ST. (2013). Pathogenesis of novel FMR1 mutations in Fragile X Syndrome. American Physician Scientists Association (APSA) 9th Annual Meeting. Chicago, IL.

 

Myrick LK, Nakamoto-Kinoshita M, Li X, Visootsak J, Lindor NM, Kirmani S, Jin P, Warren ST. (2013). Novel conventional FMR1 mutations in patients with intellectual disability. Society for Neuroscience (SFN) Annual Meeting. San Diego, CA.

 

Lectures

Myrick LK, Nakamoto-Kinoshita M, Li X, Warren ST. (2013). Pathogenesis of novel FMR1 mutations in Fragile X Syndrome. Southeast Neuroscience Consortium (SENC). Columbia, SC.

 

Myrick LK, Nakamoto-Kinoshita M, Li X, Visootsak J, Lindor NM, Kirmani S, Jin P, Chen X, Warren ST. (2013). Novel conventional FMR1 mutations in patients with intellectual disability. Southeast Medical Scientist Symposium (SEMSS). Birmingham, AL.

 

Myrick LK, Nakamoto-Kinoshita M, Li X, Visootsak J, Lindor NM, Kirmani S, Jin P, Chen X, Warren ST. (2014). Pathogenesis of novel FMR1 mutations in fragile X syndrome. Division Student Advisory Council Student Research Symposium. Emory University, Atlanta, GA.